The TEAD4–YAP/TAZ Protein–Protein Interaction: Expected Similarities and Unexpected Differences
暂无分享,去创建一个
D. Erdmann | P. Furet | F. Hofmann | P. Chène | T. Schmelzle | Yannick Mesrouze | Patrizia Fontana | C. Zimmermann | J. Hau | Tobias Schmelzle
[1] Y. Kondo,et al. YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes , 2012, Oncogene.
[2] Angela M. Liu,et al. Regulators of mammalian Hippo pathway in cancer. , 2012, Biochimica et biophysica acta.
[3] M. Sudol,et al. Structures of YAP protein domains reveal promising targets for development of new cancer drugs. , 2012, Seminars in cell & developmental biology.
[4] B. Stanger. Quit your YAPing: a new target for cancer therapy. , 2012, Genes & development.
[5] Jun O. Liu,et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. , 2012, Genes & development.
[6] Zhongmei Zhou,et al. Tumorigenesis and Neoplastic Progression YAP Promotes Breast Cell Proliferation and Survival Partially through Stabilizing the KLF 5 Transcription Factor , 2012 .
[7] Ganesh Rao,et al. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. , 2011, Genes & development.
[8] U. Gat,et al. The evolutionary history of YAP and the hippo/YAP pathway. , 2011, Molecular biology and evolution.
[9] Bin Zhao,et al. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal , 2011, Nature Cell Biology.
[10] G. Halder,et al. Hippo signaling: growth control and beyond , 2011, Development.
[11] Haiwei Song,et al. Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway , 2010, Protein & Cell.
[12] M. Sudol. Newcomers to the WW Domain-Mediated Network of the Hippo Tumor Suppressor Pathway. , 2010, Genes & cancer.
[13] D. Pan,et al. The hippo signaling pathway in development and cancer. , 2010, Developmental cell.
[14] Ravi S Kane,et al. Thermodynamics of multivalent interactions: influence of the linker. , 2010, Langmuir : the ACS journal of surfaces and colloids.
[15] Li Li,et al. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. , 2010, Genes & development.
[16] Claudio Luchinat,et al. Entropic contribution to the linking coefficient in fragment based drug design: a case study. , 2010, Journal of medicinal chemistry.
[17] D. Tomchick,et al. Structural and functional analysis of the YAP-binding domain of human TEAD2 , 2010, Proceedings of the National Academy of Sciences.
[18] Fei Chen,et al. Structural insights into the YAP and TEAD complex. , 2010, Genes & development.
[19] W. Hong,et al. Structural basis of YAP recognition by TEAD4 in the hippo pathway. , 2010, Genes & development.
[20] P. Northcott,et al. YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. , 2009, Genes & development.
[21] W. Hong,et al. TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation* , 2009, Journal of Biological Chemistry.
[22] Zhengyu Zha,et al. TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition* , 2009, Journal of Biological Chemistry.
[23] L. Amzel,et al. Impact of linker strain and flexibility in the design of a fragment-based inhibitor , 2009, Nature chemical biology.
[24] Michinori Kitagawa. A Sveinsson's chorioretinal atrophy-associated missense mutation in mouse Tead1 affects its interaction with the co-factors YAP and TAZ. , 2007, Biochemical and biophysical research communications.
[25] Jianmin Zhang,et al. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon , 2006, Proceedings of the National Academy of Sciences.
[26] M. Yaffe,et al. The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. , 2005, The Biochemical journal.
[27] H. Stefánsson,et al. A novel TEAD1 mutation is the causative allele in Sveinsson's chorioretinal atrophy (helicoid peripapillary chorioretinal degeneration). , 2004, Human molecular genetics.
[28] M. DePamphilis,et al. TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm. , 2001, Genes & development.
[29] M. Yaffe,et al. TAZ: a novel transcriptional co‐activator regulated by interactions with 14‐3‐3 and PDZ domain proteins , 2000, The EMBO journal.
[30] P. Hajduk,et al. Discovering High-Affinity Ligands for Proteins: SAR by NMR , 1996, Science.
[31] J. Fetrow. Omega loops; nonregular secondary structures significant in protein function and stability , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] F. Cohen,et al. Taxonomy and conformational analysis of loops in proteins. , 1992, Journal of molecular biology.
[33] G. Chang,et al. Macromodel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanics , 1990 .
[34] G. Rose,et al. Loops in globular proteins: a novel category of secondary structure. , 1986, Science.